SCHEMBL9944849

SCHEMBL9944849

CCNC(=O)c1cc(N)c(NC)cc1Nc1ccc(F)c(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 4/20 0.45
TDO2 P48775 4/20 0.45
FADS1 O60427 1/20 0.45
TSHR P16473 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
CNR2 P34972 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
EGFR P00533 1/20 0.40
ERBB2 P04626 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
LMNA P02545 1/20 0.40
PTGES O14684 1/20 0.39
BRAF P15056 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9946610 0.89 PTGES (0.50) IDO1TDO2FADS1TSHRMEN1
SCHEMBL9944848 0.83 MEN1 (0.42) IDO1TDO2TSHRMEN1KMT2A
SCHEMBL9944835 0.83 FADS1 (0.56) FADS1TSHRMEN1KMT2ACYP1A2
SCHEMBL9944850 0.80 PTGES (0.39) IDO1TDO2FADS1TSHRMEN1
SCHEMBL10170901 0.77 FADS1 (0.63) FADS1TSHRMEN1KMT2ACYP1A2
SCHEMBL9946577 0.76 FADS1 (0.53) FADS1TSHRMEN1KMT2ACYP1A2
SCHEMBL11992718 0.74 EGFR (0.57) FADS1TSHRMEN1KMT2ACYP1A2
SCHEMBL9944731 0.74 FADS1 (0.53) FADS1TSHRMEN1KMT2ACYP1A2
SCHEMBL9944831 0.72 FADS1 (0.51) FADS1TSHRMEN1KMT2ACYP1A2
SCHEMBL10170839 0.70 FADS1 (0.51) FADS1TSHRCYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674113-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-03-18 US disclosed
US-20120149676-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149676-A1 NOVEL COMPOUNDS PTGS1, PTGER1, PTGES IDO1 1571/4885TDO2 2391/4885FADS1 494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.